Allodynic Therapeutics
Phase 2Allodynic is a biopharma company developing Naltrexone and acetaminophen combination for migraine and neuropathic pain treatment
Founded
2019
Focus
Small Molecules
About
Allodynic is a biopharma company developing Naltrexone and acetaminophen combination for migraine and neuropathic pain treatment
Funding History
1Total raised: $5M
Seed$5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2019
LocationBoston, United States
StagePhase 2
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile